Disease-associated proteins
US9353162B2 · kind B2 · utility
1Cited by
9References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 17, 2012 |
| Grant date | May 31, 2016 |
| Priority date | — |
| Expiry date | Apr 17, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/143333
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for early diagnosis, monitoring and treatment of an ocular disorder. In particular, the invention relates to a novel protein, that is differentially transcribed and expressed in subjects suffering from retinal dystrophies and the like, such as retinal dystrophy and age-related macular degeneration compared with healthy subjects, antibodies which recognize this protein, and methods for diagnosing such conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.